Remove Enterprise Partners Remove Pricing Remove San Diego
article thumbnail

Enterprise Partners Portfolio Firm Heads To Market

socalTECH

One of the portfolio firms of San Diego-based venture capital firm Enterprise Partners , Complete Genomics is set to debut on the market Thursday, after pricing its IPO this evening. Enterprise Partners owns about 14.8 per share, below an earlier estimated range of $12.00 per share for the company.

article thumbnail

TargeGen Acquired By Sanofi-aventis

socalTECH

San Diego-based TargeGen , a firm developing small molecule kinase inhibitors for the treatment of myelofibrosis (MF) and polycythemia vera (PV), has been acquired by Sanofi-aventis, in a deal worth as much as $560M, the firm said Wednesday. TargeGen had raised over $113M in venture funding from A.M. The firm was advised by Peter J.